New Zealand vs Peru: Proportion of isolates with decreased susceptibility or resistance
New Zealand
0.4386
in 2017
Peru
0
in 2018
New Zealand rank
22nd
Peru rank
25th
Proportion of isolates with decreased susceptibility or resistance over time
- New Zealand
- Peru
How they compare
New Zealand currently reports 0.4386 against 0 in Peru, a difference of 0.4386.
The two have swapped places 3 times across 5 shared years of data; in 2009 it was Peru ahead.
New Zealand ranks 22nd and Peru ranks 25th of 51 countries.
Peru has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0.4587 | 0.5952 | 0.1366 | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, New Zealand or Peru?
- New Zealand, at 0.4386 against 0 in Peru as of 2017.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between New Zealand and Peru?
- 0.4386, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Peru?
- 5 years are reported by both, from 2009 to 2017.
- How do New Zealand and Peru rank globally for proportion of isolates with decreased susceptibility or resistance?
- New Zealand ranks 22nd and Peru ranks 25th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.